R E Holmberg1, A T Pavia, D Montgomery, J M Clark, L D Eggert. Show Affiliations » 1. Dept of Pediatrics, University of Utah School of Medicine, Salt Lake City.
Abstract
Entities: Disease
Mesh: See more » Cross Infection/drug therapyCross Infection/epidemiologyCross Infection/microbiologyDrug Therapy, CombinationErythromycin/therapeutic useHumansInfant, NewbornInfant, Premature, Diseases/drug therapyInfant, Premature, Diseases/epidemiologyInfant, Premature, Diseases/microbiologyLegionnaires' Disease/drug therapyLegionnaires' Disease/epidemiologyMaleRifampin/therapeutic useRisk FactorsWater Supply
Substances: See more » ErythromycinRifampin
Year: 1993 PMID: 8361801
Source DB: PubMed Journal: Pediatrics ISSN: 0031-4005 Impact factor: 7.124